Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
- Publisher
- British Cardiovascular Society in collaboration with the British Heart Foundation Clinical Research Collaborative
- Published
- Length
- 14 pages
- File
- 2.8 MB PDF
Download the full 14-page PDF
Free · 2.8 MB · Instant access after email
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among females, yet they represent only 25-30% of clinical trial participants. This document highlights the urgent need for:
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 From Automotive to MedTech: Proven Software Development Practices
This whitepaper outlines how MedTech can leverage automotive software development practices to enhance compliance and accelerate innovation cycles.
🔒 The Patient Confusion Crisis
Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.